Tevogen Bio Holdings, Inc. (TVGN): Advancing Immunotherapy through AI Partnerships

We recently published a list of 10 AI News You Should Not Miss. In this article, we are going to take a look at where Tevogen Bio Holdings Inc. (NASDAQ:TVGN) stands against other AI news you should not miss.

AI Growth Takes Center Stage in Trump’s Administration

While we are still in the first week of President Donald Trump’s second term, he has made several significant moves toward the development of AI. President Trump recently announced plans to fast-track the construction of power plants dedicated to AI under an emergency declaration, bypassing lengthy approval processes, as per CNBC.

Speaking at the World Economic Forum, he focused on flexibility in fuel use and suggested that coal as a backup source for emergencies. The move follows his declaration of a national energy emergency, aimed at accelerating energy infrastructure projects. Trump also unveiled Stargate, a joint venture with OpenAI, Oracle, and SoftBank, to invest heavily in AI infrastructure.

READ ALSO: 10 Important AI News on Investor Radars and 10 AI News You Should Definitely Take a Look At.

Transformative Potential of AI Across Industries

In an interview on CNBC’s ‘Squawk Box,’ Sasha Ostojic, venture partner at Playground Global discussed the current phase of AI development, emphasizing the focus on building infrastructure and tools necessary for future AI applications. He likened the U.S. government’s Stargate program and its $500 billion investment, to the Apollo program and noted its potential to drive economic activity and innovation.

Ostojic highlighted AI’s transformative potential in areas like healthcare, drug discovery, and finance as he envisioned a future where AI tools become widely accessible, similar to how smartphones made graphic design accessible to everyone. Regarding the recent changes in U.S. AI policy, Ostojic noted that while there is significant attention on AI safety and responsible development, the direction under President Trump’s administration remains unclear. He also acknowledged the growing competition from China’s AI advancements, which achieve efficiency with lower costs, and suggested that innovation will occur at both the high and low ends of the market.

For this article, we selected AI stocks by reviewing news articles, stock analysis, and press releases. We listed the stocks in ascending order of their hedge fund sentiment taken from Insider Monkey’s database of 900 hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

Tevogen Bio Holdings, Inc. (TVGN): Advancing Immunotherapy through AI Partnerships

Pressmaster/Shutterstock.com

Tevogen Bio Holdings Inc. (NASDAQ:TVGN)

Number of Hedge Fund Holders: 10

Tevogen Bio Holdings Inc. (NASDAQ:TVGN) is a clinical-stage firm focused on immunotherapy, developing targeted T-cell treatments for unmet medical needs, with an independent portfolio of AI-related patents and applications.

On January 24, Tevogen Bio expanded its partnership with Microsoft to improve its AI-driven PredicTcell technology and accelerate immunotherapy development. Through Microsoft’s AI tools and Azure platform, Tevogen aims to advance target identification, pre-clinical processes, and its ExacTcell technology pipeline. Some significant efforts include developing algorithms to study HLA-T cell interactions and preparing HPV-specific treatments using ExacTcell for its oncology candidate, TVGN 920.

Overall, TVGN ranks 9th on our list of AI news you should not miss. While we acknowledge the potential of TVGN as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than TVGN but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.